Article
Cardiac & Cardiovascular Systems
Jiwon Yun, JaYoon Gu, Hyun Kyung Kim
Summary: The study revealed that double positivity of anti-beta 2GPI and anti-PS/PT not only increased thrombotic risk but also led to increased positivity of anti-ADAMTS13 antibody, suggesting a possible association between anti-ADAMTS13 antibody and the pathophysiology of antiphospholipid syndrome.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
(2021)
Article
Immunology
Li Wu, Xuhui Fang, Fangting Lu, Yu Zhang, Yanshi Wang, Joanne Kwak-Kim
Summary: This study aimed to evaluate the effects of anticardiolipin (aCL) and/or anti-beta 2-glycoprotein-I (a beta 2GPI) antibodies, known as antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes. The results showed that infertile women with aPL had worse outcomes in terms of oocyte quality, embryo quality, and implantation capacity. Imbalanced T cell subset ratios and elevated levels of certain cytokines were noticed in these women compared to controls.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Hematology
Tessa Noordermeer, Jessica E. Molhoek, Roger E. G. Schutgens, Silvie A. E. Sebastian, Sandra Drost-Verhoef, Annet C. W. van Wesel, Philip G. de Groot, Joost C. M. Meijers, Rolf T. Urbanus
Summary: Anti-beta 2GPI and anti-prothrombin antibodies cause lupus anticoagulant (LA) through different mechanisms: anti-beta 2GPI antibodies interfere with FV activation by FXa through a direct interaction, while anti-prothrombin antibodies compete with FXa for phospholipid binding sites.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2021)
Article
Medical Laboratory Technology
Sarra Melayah, Mariem Ghozzi, Amani Mankai, Fatma Mechi, Ibtissem Ghedira
Summary: This study found that the frequencies of CCP-Ab and RF are high in patients with IgA isotype of anti-beta 2 glycoprotein I antibodies, suggesting that these patients are susceptible to developing RA.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2022)
Article
Hematology
Gabor Szabo, Ildiko Beke Debreceni, Tunde Tarr, Pal Soltesz, Bjarne Osterud, Janos Kappelmayer
Summary: Anti-beta(2)GPI autoantibodies exert multi-faceted effects in both normal and thrombophilic plasmas, prolonging Lag Time and increasing Peak Thrombin. The prolonging effect is more remarkable in plasma with inherited thrombophilic mutations.
THROMBOSIS RESEARCH
(2021)
Article
Hematology
Tessa Noordermeer, Soumaya Chemlal, Janna J. Jansma, Vossa van der Vegte, Roger E. G. Schutgens, Maarten Limper, Philip G. de Groot, Joost C. M. Meijers, Rolf T. Urbanus
Summary: This study investigated how anti-β2GPI and anti-PS/PT antibodies induce APC resistance. The results showed that anti-β2GPI and anti-PS/PT antibodies caused an increase in APC resistance in LA-positive patients and normal plasma. Anti-β2GPI antibodies interfered with the cleavage of factor V during APC-mediated inactivation of factor VIIIa, while anti-PS/PT antibodies interfered with the inactivation of factor Va and factor VIIIa by APC.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2023)
Article
Rheumatology
Antonella Capozzi, Simona Truglia, Brigitta Buttari, Serena Recalchi, Gloria Riitano, Valeria Manganelli, Silvia Mancuso, Cristiano Alessandri, Agostina Longo, Vincenzo Mattei, Elisabetta Profumo, Tina Garofalo, Roberta Misasi, Fabrizio Conti, Maurizio Sorice
Summary: The study identifies Carb-beta(2)-GPI as a new autoantigen in APS, which may be a significant marker for SN-APS patients.
Article
Hematology
Dongmei Yin, Philip G. de Groot, Marisa Ninivaggi, Katrien M. J. Devreese, Bas de Laat
Summary: Isolated lupus anticoagulant (LAC) positivity was highly associated with vascular thrombosis, even better than triple-positive samples. The levels of anti-phosphatidylserine/prothrombin antibodies (anti-PS/PT) were significantly lower in samples with isolated LAC positivity, and isolated LAC showed weaker LAC activity compared with triple-positive patients.
THROMBOSIS AND HAEMOSTASIS
(2021)
Article
Biochemistry & Molecular Biology
Suresh Kumar, Mathivanan Chinnaraj, William Planer, Xiaobing Zuo, Paolo Macor, Francesco Tedesco, Nicola Pozzi
Summary: The study reveals the distinct roles of the two disulfide bonds, C32-C60 and C288-C326, in regulating the structure and function of β(2)GPI. While the C32-C60 bond plays a structural role, the C288-C326 bond functions as an allosteric switch controlling the protein's physiological functions in a redox-dependent manner.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2021)
Article
Medicine, General & Internal
Mirna S. Yacoub, Justin Khine, Ali Najar, Sri Yadlapalli
Summary: The pathogenesis of antiphospholipid syndrome (APS) involves the action of antiphospholipid antibodies (aPLs) against Beta-2 glycoprotein-I (beta(2)GPI). The association of IgA isotypes with APS and thrombosis is controversial.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Article
Rheumatology
Marwa Elkhalifa, Ana-Maria Orbai, Laurence S. Magder, Michelle Petri, Graciela S. Alarcon, Caroline Gordon, Joan Merrill, Paul R. Fortin, Ian N. Bruce, David Isenberg, Daniel Wallace, Ola Nived, Rosalind Ramsey-Goldman, Sang-Cheol Bae, John G. Hanly, Jorge Sanchez-Guerrero, Ann E. Clarke, Cynthia Aranow, Susan Manzi, Murray Urowitz, Dafna D. Gladman, Ken Kalunian, Victoria P. Werth, Asad Zoma, Sasha Bernatsky, Munther Khamashta, Soren Jacobsen, Jill P. Buyon, Mary Anne Dooley, Ronald van Vollenhoven, Ellen Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffery P. Callen, Sam Lim, Murat Inanc, Diane L. Kamen, Anisur Rahman, Kristjan Steinsson, Andrew G. Franks
Summary: The study assessed the prevalence of anti-beta 2 glycoprotein I IgA in SLE compared to other rheumatic diseases and its association with disease manifestations. Results showed that anti-beta 2 glycoprotein I IgA is more common in patients with SLE, particularly in those of African descent.
Article
Medicine, General & Internal
Martina Frodlund, Tomas Walhelm, Charlotte Dahle, Christopher Sjowall
Summary: In patients with recent-onset SLE, a substantial percentage tested positive for at least one aPL isotype or the lupus anticoagulant test over time. Levels of all six aPL isotypes numerically decreased from inclusion to last follow-up. The presence of IgG aCL was significantly associated with myocardial infarction and miscarriage, while IgG/IgA anti-beta 2GPI was linked to miscarriage.
FRONTIERS IN MEDICINE
(2021)
Article
Cell Biology
Gloria Riitano, Antonella Capozzi, Serena Recalchi, Daniela Caissutti, Agostina Longo, Vincenzo Mattei, Fabrizio Conti, Roberta Misasi, Tina Garofalo, Maurizio Sorice, Valeria Manganelli
Summary: This study analyzed the induction of Tissue Factor (TF) expression in endothelial cells by anti-beta 2-GPI antibodies from patients with APS through a LRP6 signal transduction pathway involving lipid rafts. The results showed that the anti-beta 2-GPI antibodies triggered LRP6 phosphorylation and subsequent activation of beta-catenin, leading to TF expression on the cell surface.
Article
Biochemistry & Molecular Biology
Tatiana Reshetnyak, Fariza Cheldieva, Maria Cherkasova, Alexander Lila, Evgeny Nasonov
Summary: This study investigates the role of IgA antibodies to cardiolipin (aCL) and IgA antibodies to beta-2 glycoprotein 1 (anti-beta(2)-GP1) in the development of vascular complications in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). The results show that the levels of IgA aCL and IgA anti-beta(2)-GP1 are significantly higher in APS patients compared to SLE patients and the control group. These antibodies are closely associated with thrombosis in APS, demonstrating high specificity but low sensitivity for the diagnosis of APS.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Medical Laboratory Technology
Sarra Melayah, Mariem Ghozzi, Ibtissem Ghedira, Amani Mankai
Summary: This study found that antiphospholipid antibodies (aPL) were common in patients with articular manifestations, mainly directed against beta(2)GPI. However, the role of these antibodies remains to be specified.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2023)